RecruitingPhase 4NCT05192057

Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease

A Randomized Controlled Trial on Hypertonic Saline Inhalation in Patients With Nodular-bronchiectatic Mycobacterium Avium Complex Pulmonary Disease

Sponsor

Radboud University Medical Center

Enrollment

30 participants

Start Date

May 20, 2022

Study Type

INTERVENTIONAL

Conditions

Nontuberculous Mycobacterial Lung Disease Mycobacterium Avium Complex

Summary

The SALINE trial will investigate the effect of Hypertonic Saline inhalation plus best supportive care on burden of symptoms, clearance of mycobacteria and functional capacities in participants with Mycobacterium avium complex lung disease and compare the effect to treatment with best supportive care alone.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Hypertonic Saline inhalation for people with mycobacterium avium complex and nontuberculous mycobacterial lung disease. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.